Supporting our findings, the analysis of these TGCA gene expression dataset revealed that ID2 should be considered as an unfavourable prognostic gene (Fig. 7A) whereas ETS2 as a favourable prognostic gene for patients with glioma (Fig. 7B). The gene discussed is ID2; the disease is central nervous system cancer.